Clinical Value of Autoantibody Prognostic Markers in Tumor Immune Checkpoint
Inhibitor Therapy / 中国肺癌杂志
Chinese Journal of Lung Cancer
;
(12): 534-540, 2022.
Article
in Chinese
| WPRIM
| ID: wpr-939743
ABSTRACT
Serum autoantibody markers have the advantages of easy specimen acquisition, simple detection technology and dynamic real-time monitoring. With the wide application of immune checkpoint inhibitors in the treatment of malignant tumors, autoantibody markers in predicting tumor immune checkpoint inhibitors efficacy and forecasting irAEs (immune related adverse events) show good prediction of potential. This review mainly focused on the progress of autoantibody markers in the prediction of therapeutic effect and the monitoring of irAE in tumor immunotherapy.
.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Prognosis
/
Immune Checkpoint Inhibitors
/
Immunotherapy
/
Lung Neoplasms
/
Neoplasms
Type of study:
Prognostic study
Limits:
Humans
Language:
Chinese
Journal:
Chinese Journal of Lung Cancer
Year:
2022
Type:
Article
Similar
MEDLINE
...
LILACS
LIS